EIA
TMO icon

Edgemoor Investment Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Edgemoor Investment Advisors’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$8.89M Buy
18,085
+814
+5% +$442K 0.7% 38
2025
Q4 		$10M Sell
17,271
-32
-0.2% -$18.1K 0.78% 32
2025
Q3 		$8.39M Sell
17,303
-5,621
-25% -$2.62M 0.65% 37
2025
Q2 		$9.29M Buy
22,924
+4,702
+26% +$1.97M 0.8% 35
2025
Q1 		$9.07M Sell
18,222
-169
-0.9% -$91.5K 0.83% 36
2024
Q4 		$9.57M Sell
18,391
-327
-2% -$180K 0.84% 31
2024
Q3 		$11.6M Buy
18,718
+125
+0.7% +$74K 1.01% 24
2024
Q2 		$10.3M Buy
18,593
+809
+5% +$463K 0.96% 27
2024
Q1 		$10.3M Buy
17,784
+2,115
+13% +$1.19M 0.98% 27
2023
Q4 		$8.32M Buy
15,669
+2,101
+15% +$1.02M 0.87% 29
2023
Q3 		$6.87M Sell
13,568
-1,755
-11% -$935K 0.81% 33
2023
Q2 		$7.99M Buy
+15,323
New +$8.27M 0.9% 30
2014
Q1 		– Sell
-96,032
Closed -$10.7M – 130
2013
Q4 		$10.7M Sell
96,032
-1,720
-2% -$171K 1.7% 19
2013
Q3 		$9.01M Sell
97,752
-2,171
-2% -$196K 1.57% 27
2013
Q2 		$8.46M Buy
+99,923
New +$8.32M 1.5% 26

Other funds holding TMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Edgemoor Investment Advisors's TMO Position: Q1 2026 in Review

Edgemoor Investment Advisors increased its Thermo Fisher Scientific (TMO) stake by 4.7% in Q1 2026, buying an estimated $442K and bringing the position to 18,085 shares worth $8.89M. The position accounts for 0.7% of the portfolio, ranked #38.

Edgemoor Investment Advisors first reported a position in TMO in Q2 2013 and has held it in 15 quarters since. The position peaked at $11.6M in Q3 2024. 2,588 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Edgemoor Investment Advisors held 18,085 shares of Thermo Fisher Scientific worth $8.89M as of Q1 2026.
  • Edgemoor Investment Advisors bought 814 Thermo Fisher Scientific shares in Q1 2026, an estimated $442K.
  • Thermo Fisher Scientific made up 0.7% of Edgemoor Investment Advisors's portfolio in Q1 2026, its #38 holding.
  • Edgemoor Investment Advisors first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 15 quarters since.
  • Edgemoor Investment Advisors's Thermo Fisher Scientific position peaked at $11.6M in Q3 2024.
  • 2,588 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Edgemoor Investment Advisors's 13F filing for Q1 2026, filed 13 May 2026.